<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03219788</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00008715892</org_study_id>
    <nct_id>NCT03219788</nct_id>
  </id_info>
  <brief_title>Remifentanil and Desflurane Inhalational Anesthesia in Bariatric Surgeries</brief_title>
  <official_title>The Recovery Profile of Different Doses of Remifentanil After Desflurane Inhalational Anesthesia for Bariatric Surgeries: Two Centers Controlled Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of obese and overweighted persons doubled since 1980. They are 600 million in 2014
      all over the world. Obesity results in anatomical, physiological and pharmacological changes
      which represent a challenge for every anesthetist. Difficult airway increases by 30% with
      obesity and so awake extubation are the preferred technique. Coughing can be alleviated by
      opioid receptors which play a role in the cough reflex. Remifentanil may be useful as an
      ultra-short acting opioid and its effect swiftly and predictably disappears after cessation.
      An emergence cough is attenuated by remifentanil administered via continuous infusion (TCI),
      and the expected effective effect-site concentrations investigated have ranged from 1.5 to
      2.5 ng.ml/L.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators designed this study to examine the effect of different small doses of
      Remifentanil on the incidence of cough reflex during emergence from anesthesia in obese
      patients undergoing bariatric surgery. The investigators will study if these small doses will
      delay the recovery of the patient or not. The other expected side effects will be observed
      eg. Respiratory depression. Time to the first painkiller required will be registered
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 20, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in hemodynamic</measure>
    <time_frame>within the first 24 hours</time_frame>
    <description>Mean blood pressure and heart rate will be recorded before surgery and combined with all the other study items at the end of surgery, at the extubation time, after 5 minutes in PACU, after 10 minutes in Postanesthesia Care Unit (PACU) and he last registered reading in PACU.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>antitussive effect</measure>
    <time_frame>within the first 24 hours</time_frame>
    <description>cough assessment at recovery time 0 no cough
single cough
cough episode less than five seconds or multiple coughs
sustained attack of cough lasts more than five seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory depression</measure>
    <time_frame>within the first 24 hours</time_frame>
    <description>In the postoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>within the first 24 hours</time_frame>
    <description>The duration from extubation till the first painkiller and pain severity using VAS at the extubation time will recorded</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anesthesia Emergence</condition>
  <arm_group>
    <arm_group_label>Group 1(Normal saline)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients who will receive placebo (one ml normal saline). The drug will be given after closure of desflurane at an exhaled MAC of 0.3.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (Remifentanil 0.1 ug/kg)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will receive remifentanil at a dose of 0.1 ug/kg. The drug will be given after closure of desflurane at an exhaled MAC of 0.3.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 ((Remifentanil 0.2 ug/kg))</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will receive remifentanil at a dose of 0.2 ug/kg. The drug will be given after closure of desflurane at an exhaled MAC of 0.3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>All the patient will be anesthetized using a standard anesthetic technique. One ml normal saline will be given</description>
    <arm_group_label>Group 1(Normal saline)</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil 0.1 ug/kg</intervention_name>
    <description>All the patient will be anesthetized using a standard anesthetic technique. One ml normal saline contains 0.1 ug/kg Remifentanil will be given</description>
    <arm_group_label>Group 2 (Remifentanil 0.1 ug/kg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil 0.2 ug/kg</intervention_name>
    <description>All the patient will be anesthetized using a standard anesthetic technique. One ml normal saline contains 0.2 ug/kg Remifentanil will be given</description>
    <arm_group_label>Group 3 ((Remifentanil 0.2 ug/kg))</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ageâ‰¥ 18 years

          2. Subject has signed informed consent for bariatric laparoscopic surgery.

          3. Subject must be ASA I or ASA II according to the American Society of Anesthetists
             classification.

        Exclusion Criteria:

          1. Age &lt; 18 years.

          2. Smoking patient.

          3. Hypertension.

          4. Bronchial asthma.

          5. Obstructive sleep apnea syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed S Ali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate profossor of anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed S Ali, MD</last_name>
    <phone>0020882413201</phone>
    <email>msali58@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sayed K Abd-Elshafy, MD</last_name>
    <phone>0020882413201</phone>
    <email>sayed_k_72@yahoo.com</email>
  </overall_contact_backup>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>July 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>July 14, 2017</last_update_submitted>
  <last_update_submitted_qc>July 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Dr Mohamed Shaaban Ali, PhD, MD</investigator_full_name>
    <investigator_title>Associate Profossor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>emergence</keyword>
  <keyword>remifentanil</keyword>
  <keyword>recovery</keyword>
  <keyword>desflurene</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

